O

Orion Oyj
OMXH:ORNBV

Watchlist Manager
Orion Oyj
OMXH:ORNBV
Watchlist
Price: 45.23 EUR 1.89% Market Closed
Market Cap: 6.3B EUR
Have any thoughts about
Orion Oyj?
Write Note

Net Margin
Orion Oyj

18.5%
Current
20%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
18.5%
=
Net Income
232.4m
/
Revenue
1.3B

Net Margin Across Competitors

Country FI
Market Cap 6.4B EUR
Net Margin
18%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 710.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.5B USD
Net Margin
17%
Country US
Market Cap 251.1B USD
Net Margin
19%
Country CH
Market Cap 202.7B CHF
Net Margin
20%
Country CH
Market Cap 183.3B CHF
Net Margin
35%
Country UK
Market Cap 162.4B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%
No Stocks Found

Orion Oyj
Glance View

Market Cap
6.4B EUR
Industry
Pharmaceuticals

Orion Oyj, a Finnish pharmaceutical and diagnostics company, has a storied history that dates back to 1917, when it was formed to meet the healthcare needs of the Finnish population. Over the decades, Orion has evolved into a key player in the European healthcare landscape, driven by its commitment to innovation and high-quality products. The company operates in two main segments: Prescription Pharmaceuticals, which includes medication for various therapeutic areas such as pain management, oncology, and neurology; and Animal Health, offering veterinary medicines and healthcare solutions. With a robust pipeline of new drugs and a focus on research and development, Orion is well-positioned to address the growing global demand for effective healthcare solutions. For investors, Orion presents a compelling narrative of stability and growth. The company has achieved consistent revenue growth and profitability, bolstered by strategic partnerships and an expansive international market presence. Orion maintains a strong balance sheet, allowing it to invest in future innovation while returning value to shareholders through dividends. The demand for its products is supported by an aging population and increasing health challenges, creating a favorable environment for sustained demand. In a rapidly changing world, Orion Oyj stands out as a resilient and adaptive company, embodying the prudent investment strategy espoused by legends like Warren Buffett and Charlie Munger.

ORNBV Intrinsic Value
60.97 EUR
Undervaluation 26%
Intrinsic Value
Price
O

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
18.5%
=
Net Income
232.4m
/
Revenue
1.3B
What is the Net Margin of Orion Oyj?

Based on Orion Oyj's most recent financial statements, the company has Net Margin of 18.5%.